Adult Cardiology > Elixir Medical Corporation > DESyne® BD NOVOLIMUS™ Eluting Coronary Stent System

DESyne® BD NOVOLIMUS™ Eluting Coronary Stent System

Elixir Medical Corporation - DESyne BD

The Elixir DESyne BD Novolimus-Eluting Coronary Stent System represents a significant advancement in biodegradable coating technology, eliminating the need for a primer coating and achieving a bare metal surface within 6 -9 months, while providing excellent DES results.

Stent Design

Cobalt Chromium Platform

The DESyne BD stent is manufactured on a clinically-proven cobalt chromium platform to maximize deliverability.


Biodegradable Polymer Coating

Biodegradable Polymer Coating

Low Drug Dose

Established Safety and Performance

Proprietary Drug Facilitates Superior Clinical Efficacy1

Safety Profile

Elixir conducted five separate trials which included over 400 patients for the prevention of restenosis using DESyne and DEsyne BD stent systems resulting in excellent and sustained safety and effectiveness clinical outcomes.

Clinical Data

Elixir Medical has completed the EXCELLA BD randomized trial for the DESyne BD Novolimus-Eluting Stent System. 
The EXCELLA BD Trial was a randomized, prospective, multicenter, single-blind, non-inferiority study evaluating the DESyne
BD Novolimus Eluting Coronary Stent System (CSS) with resorbable polylactide-based polymer compared to the Endeavor Zotarolimus Eluting Coronary Stent System. 

Learn more about EXCELLA BD